retatrutide obesity trial results #type2diabetes #obesity #weightreduction #hba1c #glucosecontrol #sideeffects #triumph2trial retatrutide side effects clinical trial

those on another DPP-4 inhibitor and/or on a sulfonylurea entered a 4-8 week run-in period in which they were maintained on metformin and switched to sitagliptin (100 mg)

If you've been taking oral B12 supplements without feeling a difference, a shot is the most reliable way to find out whether the issue is your B12 levels or something else

Major Findings The study found that GLP-1RAs showed promise for improving cognitive function and reducing the risk of dementia, particularly in individuals with diabetes

Potentially climbing to over $200 billion in just six years

Retatrutide activates three metabolic receptors: GLP-1, GIP, and glucagon